𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Developmental aspects of endothelin receptors in rabbit lower urinary tract

✍ Scribed by Motoaki Saito; Jamshid Latifpour; Robert M. Weiss


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
173 KB
Volume
19
Category
Article
ISSN
0733-2467

No coin nor oath required. For personal study only.

✦ Synopsis


Since evidence of development/age-related alterations of endothelin receptors in circulation and respiration systems has been increasing, we attempted to investigate the pharmacological characterization of endothelin receptors in neonatal, premature, and mature male rabbit lower urinary tract. The biochemical properties of ET receptors were examined in the lower urinary tracts of 1-day (neonatal)-, 6-week (premature)-, and 1-year(mature)-old male rabbits with binding technique utilizing [ 125 I]ET-1.

The rank orders of the densities (B max values) of endothelin receptors in the bladder dome, bladder base, and urethra of different aged rabbits were bladder dome, 1 day > 6 week ΠΌ 1 year, bladder base, 1 day > 6 week ΠΌ 1 year, and urethra, 1 day > 6 week > 1 year. The pharmacological profiles of these binding sites inhibited by various kinds of endothelin receptor compounds showed similar K i values and similar proportions of endothelin receptor subtypes in the same regions of 1-day-, 6-week-, and 1-year-old animals.

Our data clearly demonstrated the presence of regional difference and developmentrelated changes in the density and subtype specificity of endothelin receptors in the lower urinary tract of the male rabbit.


πŸ“œ SIMILAR VOLUMES


Developmental toxicity and toxicokinetic
✍ Treinen, K.A.; Louden, C.; Dennis, M.J.; Wier, P.J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

Embryo-fetal development studies with toxicokinetic evaluations were conducted in rats and rabbits after oral or intravenous administration of two endothelin receptor antagonists. In the rat studies, females were administered SB-217242 (0.01-300 mg/kg/day) orally or SB-209670 (0.01-50 mg/kg/day) int